Dispose of the Needle Safely: Place the used needle in a sharps container to avoid injury
It is a development-program designation rather than a description of established activity, and the compound remains investigational
These medications have varying dosing frequencies, such as daily, weekly, or monthly injections, making them convenient options for patients
Clinical studies indicate that semaglutide can facilitate an average reduction of 15% in body mass over 68 weeks, with participants who completed the full treatment achieving an average loss of 22.7%
Implications for insurers Insurers should consider the impact of AOMs across their business: Assess how AOMs may impact protection, morbidity, and longevity experience Review trend assumptions to identify whether changes are needed Establish processes to keep on top of this fast-moving space Consider new lapse risks Assess how AOMs might affect underwriting and claims Insured impacts and reviewing trend assumptions Insurers should consider adjustments to their specific mortality and morbidity improvement assumptions to reflect AOMs